ArticleAnnals of hematology2026

Association between proton pump inhibitor co-medication and treatment switching in dasatinib-treated patients with chronic myeloid leukemia: a German real-world evidence study.

Sabrina Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.